Debevoise represents Bear, Stearns & Co. as underwriter in Endo Pharmaceutical secondary stock offerings
August 1, 2004
Debevoise & Plimpton represented Bear, Stearns & Co. as underwriter in secondary offerings of common stock of Endo Pharmaceuticals, totaling $358 million.